• Skip to primary navigation
  • Skip to main content
  • Skip to footer
 

Anaheim Lighthouse

Your Beacon of Hope!

Questions? Call Now(877) 959-5909
  • About Us
  • What We Treat
  • Treatment Options
  • Our Facility
  • Admissions
  • Learn About
  • Contact Us
  • Our Team
  • Awards & Recognitions
  • Yelp & Google Reviews
  • Client Testimonials
  • Accreditation & Licensing
  • Employment Opportunities
  • Press Releases
  • Alchohol Abuse
  • Drug Addiction
  • Dual Diagnosis
  • Trauma Victims
  • Veterans Program
  • Holistic Treatment
  • Specialties
  • Detox Alcohol & Drugs
  • Drug Rehab
  • Inpatient Rehab
  • Complete Residential Care
  • Partial Hospitalization
  • Intensive Outpatient
  • Intervention
  • Family Support
  • Verify Insurance
  • Financing Options
  • Coronavirus Safety Procedures
  • Alcoholism
  • Health and Wellness
  • Life in Recovery
  • Love and Relationships
  • Opioid Addiction
  • Parent Resources
  • Relapse and Recovery
  • Substance Abuse
  • Opioids
  • Sleeping Pills
  • Stimulants

DEA Reduces Opioid Manufacturing for 2017

Oct 4 2016
Categories:Updates from the Center

DEA Reduces Amount of Opioid Controlled Substances to be Manufactured in 2017

The United States Drug Enforcement Administration (DEA) announced in a press release dated October 4 that it has reduced the amount of virtually every Schedule II opiate and opioid medication that can be manufactured in the United States for the year 2017.  The Final Order published in the Federal Register reduces the amount of of most quantities by 25 percent or more.

Some medicines were reduced by more, such as hydrocodone, which will be 66 percent of last year’s level.  Demand for these opioid medicines, represented by prescriptions written by DEA-registered practitioners, has decreased according to sales data obtained by DEA from IMS Health, a company that provides insurance companies with data on prescriptions written and prescription medications sold in America.

The Aggregate Production Quota (APQ) established by the Final Order is the total amount of a controlled substance necessary to meet the estimated medical, scientific, research, industrial, and export needs for the year and for the maintenance of reserve stocks. The 2017 APQ has been reduced for oxycodone, hydrocodone, fentanyl, hydromorphone, morphine, and other such medications. Much of this reduction is attributed to the elimination of a 25 percent buffer that was added to the APQ annually in 2013 through 2016 to guard against shortages.

The order is intended to target the supply of opioids available and thus indirectly the extent of abuse. The 2015 National Survey on Drug Use and Health (NSDUH) released last month found 6.5 million Americans over the age of 12 used controlled prescription medicines non-medically during the past month, second only to marijuana and more than past-month users of cocaine, heroin, and hallucinogens combined. Earlier this year the CDC issued guidelines to practitioners recommending a reduction in prescribing opioid medications for chronic pain, while the Surgeon General issued a letter to all doctors about opioid prescriptions.  For many years, the DEA and other organizations have been educating practitioners, pharmacists, manufacturers, and the public about the potential dangers of the misuse of opioid medications.

When Congress passed the Controlled Substances Act (CSA), the quota system was intended to reduce or eliminate diversion from “legitimate channels of trade” by controlling “the quantities of the basic ingredients needed for manufacture.” The purpose of quotas are to provide for the adequate and uninterrupted supply for legitimate medical need of the types of schedule I and II controlled substances that have a potential for abuse, while limiting the amounts available to prevent diversion to illicit usage.  DEA establishes APQs for more than 250 Schedule I and II controlled substances each year.

In setting the APQ, DEA considers data from many sources, including estimates of the legitimate medical need, estimates of retail consumption based on prescriptions dispensed, manufacturers’ data on actual production, sales, inventory, exports, product development needs, and manufacturing losses, data from DEA’s own internal system for tracking controlled substance transactions, and the history of past quota.  Once the aggregate quota is set, the DEA allocates individual manufacturing and procurement quotas to those companies that apply for manufacturing.  The DEA may revise a company’s quota at any time during the year if change is warranted due to increased sales or exports, new manufacturers entering the market, new product development, or product recalls.

Thia is another step in right direction by our government agencies to help end the terrible opioid epidemic that ravages our nation.

Confidential Contact Form

  • This field is for validation purposes and should be left unchanged.

Privacy Policy

Learn About Lighthouse

  • Affordable Drug Rehab and Detox Center
  • CARF Certified
  • Homelike setting and world-class facilities
  • State licensed and certified
  • Most PPO insurance accepted
  • Specialized Alcohol and Drug Treatment Programs
  • Licensed and well-qualified professional staff
KNOW MORE

BLOG CATEGORIES

All Categories Alcoholism Drug Facts Health and Wellness Love and Relationships Opioid Addiction

Recent Posts

Snort Xanax

Can You Snort Xanax? Dangers You Should Know

March 20 2023
Alcoholism

5 Ways To Spot A Closet Drinker

March 13 2023
St. Patrick's Day In Addiction Recovery

Surviving St. Patrick's Day In Recovery

March 3 2023
Snort Hydrocodone

Can You Snort Hydrocodone? Here's Why You Shouldn't?

February 17 2023
Valentine's Day When You're Single And Sober

How To Spend Valentine's Day When You're Single And Sober

February 6 2023

WHY CHOOSE LIGHTHOUSE

  • Affordable Drug Rehab and Detox Center
  • CARF Certified
  • Homelike setting and world-class facilities
  • State licensed and certified
  • Most PPO insurance accepted
  • Specialized Alcohol and Drug Treatment Programs
  • Licensed and well-qualified professional staff

Google Reviews

Christopher Tamburello

Absolutely loved this place. Great counselors- my counselor was Johnny. Great Alumni aftercare program that helps keep you connected. I highly recommend Lighthouse for anyone struggling with alcohol or drug addiction.

Josh Mugol

When I first stepped in to fill out the paper work to get admitted to housing, I immediately felt welcomed. If you treat the staff, therapists, and doctors with respect and use common courtesy, you will get more in return. The staff is run by former addicts/alcoholics so they...

Teresa Egan

The Lighthouse saved my life. I was willing to do whatever it takes to learn how to live a new way of life. Before I came into the program I was a hollow shell just wanting to die.. The staff loved me until I could love myself, and taught me how to deal with myself. I have a...

No Related Articles

We Accept Insurance

Don’t see your provider? Contact us to confirm coverage.

3 Easy Options to Get Started or Learn More

You Call Us

We are here to answer your questions. Learn about detox, treatment, costs, or anything else. Give us a call now.
(877) 959-5909

We Call You

Complete this secure form to receive a fast response from our support team
  • This field is for validation purposes and should be left unchanged.

Verify Your Insurance

Quickly confirm your coverage using our fast & easy verification system. We accept most insurances (and financing).
Verify My Insurance
  • About Us
  • What We Treat
  • Treatment Options
  • Our Facility
  • Admissions
  • Learn About
  • Contact Us

Connect With Us

(877) 959-5909

1320 West Pearl Street, Anaheim, CA 92801

Licensed and Certified by the State Department of Health Care Services 300188AP Exp. 5/31/2024
Licensed by the State Department of Health Care Services 300188CP Exp. 5/31/2024
Certified by the State Department of Health Care Services 300188FP Exp 5/31/2023

Copyright © 2022 Anaheim Lighthouse. All Rights Reserved. | Privacy Policy | Web Accessibility